期刊文献+

苯唑西林耐药金黄色葡萄球菌的临床分离和药敏情况分析 被引量:4

原文传递
导出
摘要 目的了解云南省第二人民医院金黄色葡萄球菌的临床分布及耐药性特征,为临床合理使用抗生素、降低院内感染率提供参考依据。方法常规方法做细菌培养,采用VITEK2Compact全自动微生物分析仪对临床分离病原菌进行鉴定和药敏试验,使用WHONET5.5软件对金黄色葡萄球菌进行数据统计分析。结果云南省第二人民医院2009年8月至2010年7月共分离出金黄色葡萄球菌200株,160株为耐甲氧西林金黄色葡萄球菌(MRSA),占80%,甲氧西林敏感金黄色葡萄球菌(MSSA)仅40株,占20%;最常见的感染部位是下呼吸道和皮肤;MRSA对青霉素、环丙沙星、庆大霉素、红霉素、克林霉素、四环素、磺胺甲恶唑/甲氧苄啶耐药率均明显高于MSSA菌株,二者差异具有统计学意义;MRSA对万古霉素、替考拉宁和利耐唑胺敏感率为100%,对奎奴普丁/达福普叮敏感率达98.7%,未发现万古霉素中介株(VISA)和耐药株(VRSA);MRSA同时对庆大霉素、环丙沙星、红霉素和克林霉素耐药的菌株为138株,占86.25%,是主要的耐药模式;10株金黄色葡萄球菌为红霉素耐药克林霉素敏感株,D试验阳性率为40%。结论 MRSA对多种抗菌药物耐药率高,绝大多数MRSA菌株为多重耐药菌株;实验室应加强MRSA耐药性和克林霉素诱导型耐药监测,规范临床用药,隔离MRSA感染者,防止医源性传播。
出处 《中华临床医师杂志(电子版)》 CAS 2011年第5期130-132,共3页 Chinese Journal of Clinicians(Electronic Edition)
  • 相关文献

参考文献8

  • 1李勇勇,黄文祥.耐甲氧西林金黄色葡萄球菌的感染现状与治疗进展[J].国外医药(抗生素分册),2010,31(1):19-23. 被引量:31
  • 2孙宏莉,王辉,陈民钧.甲氧西林耐药的金黄色葡萄球菌耐药性及分子流行病学调查[J].中华微生物学和免疫学杂志,2005,25(2):137-141. 被引量:61
  • 3Carvalho KS,Mamizuka EM,Gontijo Filho PP.Methicillin /Oxacillin-resistant Staphylococcus aureus as a hospital and public health threat in Brazil.Braz J Infect Dis,2010,14:71-76.
  • 4Nevet A,Ashkenazi S,Samra Z,et al.Community-associated methicillin-resistant Staphylococcus aureus infections in Israel.Isr Med Assoc J,2010,12:428-430.
  • 5Shenoy MS,Bhat GK,Kishore A,et al.Significance of MRSA strains in community associated skin and soft tissue infections.Indian J Med Microbiol,2010,28:152-154.
  • 6Stevens AM,Hennessy T,Baggett HC,et al.Methicillin-Resistant Staphylococcus aureus carriage and risk factors for skin infections,Southwestern Alaska,USA.Emerg Infect Dis,2010,16:797-803.
  • 7刘于红,邹曰坤,李大伟,张毅,张萍,张志成.万古霉素与利奈唑胺治疗MRSA菌血症疗效比较[J].山东医药,2009,49(52):69-70. 被引量:3
  • 8Tasbakan MS,Korkmaz Ekren P,Pullukcu H,et al.Comparison of teicoplanin and linezolid therapies in patients with methicillin-resistant Staphylococcus aureus pneumonia acquired from respiratory intensive care unit.Mikrobiyol Bul,2010,44:357-366.

二级参考文献47

  • 1林东昉,吴菊芳,张婴元,郑经川,缪竞智,郑丽叶,盛瑞媛,周新,沈华浩,吴卫红,周乐,汪复.利奈唑胺与万古霉素治疗革兰阳性菌感染的随机、双盲、对照、多中心临床试验[J].中国感染与化疗杂志,2009,9(1):10-17. 被引量:56
  • 2Trautmann M, Pollitt A, Loh U,et al. Implementation of an intensified infection control program to reduce MRSA transmissions in a German tertiary care hospital [J]. Am J Infect Control, 2007, 35(10):643.
  • 3Jarvis WR, Schlosser J, Chinn R Y, et al. National prevalence of methicillin -resistant Staphylococcus aureus in inpatients at US health care facilities, 2006[J]. Am J Infect Control, 2007, 35(10):631.
  • 4Nathwani D, Morgan M, Masterton RG,et al. Guidelines for UK practice for the diagnosis and management of rnethicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community[J]. J Antimicrob Chemother, 2008, 61 (5):976.
  • 5Aguiar-Alves F, Medeiros F, Fernandes O, et al.New Staphylococcus aureus genotyping method based on exotoxin(set)Genes[J]. J Clin Microbiol, 2006, 44(8):2728.
  • 6Gomes AR, Vinga S, Zavolan M,et al.Analysis of the genetic variability of virulence-related loci in epidemic clones of methicillin-resistant Staphylococcus aureus[J]. Antimicrob Agents Chemother, 2005, 49(1):366.
  • 7Zaraket H, Otsuka T, Saito K,et al.Molecular characterization of methicillin-resistant Staphylococcus aureus in hospitals in Niigata, Japan: divergence and transmission[J]. Microbiol Immunol, 2007, 51 (2): 171.
  • 8Faria NA, Oliveira DC, Westh H, et al. Epidemiology of emerging methicillin-resistant Staphylococcus aureus (MRSA) in Denmark: a nationwide study in a country with low prevalence of MRSA infection[J]. J Clin Microbiol, 2005, 43(4): 1836.
  • 9Sibbald M J, Ziebandt AK, Engelmann S, et al. Mapping the Pathways to staphylococcal pathogenesis by comparative secretomics[J]. Microbiol Mol Biol Rev, 2006, 70(3):755.
  • 10Chambers HF.Community-associated MRSA-resistance and virulence converge [J]. N Engl J Med, 2005, 352(14):1485.

共引文献92

同被引文献26

  • 1刘庆中,周铁丽,李超,黄海霞.耐甲氧西林金黄色葡萄球菌暴发流行菌株的基因分型研究[J].中华医院感染学杂志,2006,16(10):1086-1088. 被引量:20
  • 2Pinho MG,Filipe SR, de Lencastre H, et al. Complement- ation of the essential peptidoglycan transpeptidase func- tion of penicillin-binding protein 2(PBP2)by the drug re- sistance protein PBP2A in staphylococcus aureus[J]. J Bacteriol, 2001,183(22) : 6525-6531.
  • 3叶应妩,王毓三,申子瑜.全国临床经验操作过程.3版.南京:东南大学出版社.2006:736-753.
  • 4Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial suscptibility testing; Nineteenth Informational Supplement. [ M100-S17 ]. 2007.
  • 5CLSI. Performance Standards for Antimicrobial Susceptibility Testing;Eightteenth Informational Supplement[S].2008.
  • 6Ajantha GS,Kulkarni RD,Shetty J. Phenotypic detection of inducible clindamycin resistance among Staphylococcus aureus isolates by using the lower limit of recommended inter-disk distance[J].Indian Journal of Pathology & Microbiology,2008.376-378.
  • 7Yilmaz G,Aydin K,Iskender S. Detection and prevalence of inducible clindamycin resistance in staphylococci[J].Journal of Medical Microbiology,2007.342-345.
  • 8Mendes RE,Sader HS,Deshpande LM. Characterization of baseline methicillin-resistant Staphylococcus aureus isolates recovered from phase IV clinical trial for linezolid[J].Journal of Clinical Microbiology,2010.568-574.
  • 9Saderi H,Emadi B,Owlia P. Phenotypic and genotypic study of macrolide,lincosamide and streptogramin B(MLSB)resistance in clinical isolates of Staphylococcus aureus in Tehran,Iran[J].Medical Science Monitor,2011.BR48-BR53.
  • 10Pal N,Sharma B,Sharma R. Detection of inducible clindamycin resistance among Staphylococcal isolates from different clinical specimens in western India[J].Journal of Postgraduate Medicine,2010.182-185.

引证文献4

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部